Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2011 FY- Text added to 2012 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
Abbott, accommodate, adalimumab, antibody, Appraisal, Bayer, Belgium, bimatoprost, budget, category, China, cleared, Cosopt, DCP, Denmark, disagree, dossier, dropped, ease, Excellence, EYLEA, filer, Finland, forfeited, gene, Genetech, Gevokizumab, goal, heightened, Humera, injunctive, interfering, Italian, LUMIGAN, Luveniq, Lux, Merck, modulate, move, MRP, mutual, nanotechnology, necessity, NICE, nonrecurring, optimistic, orthopedic, partnership, path, peptide, physician, plc, prioritizing, proceed, protein, reauthorization, recurrence, registry, relief, ribonucleic, Santen, satisfactory, Spanish, sponsorship, Sweden, tafluprost, tangible, unclear, underestimated, understaffing, voclosporin, workload, Xalatan, XOMA, ZIOPTAN
Removed:
acted, adjustment, age, AION, analyze, apparent, assigned, blind, BrachySil, clinically, consulting, continuation, define, degeneration, detachable, determining, developmental, discontinued, dissemination, dose, elimination, ending, excluding, facility, force, gave, grain, historically, improved, inclusion, inconvenient, initiation, irreversible, iv, laser, lead, Medidur, monetary, occlusion, occurrence, onset, passage, photocoagulation, pilot, pro, progression, rata, ratably, receiving, recognizing, remittance, repeat, requirement, resale, RhuFab, rice, sensitivity, shareholder, sharing, sharply, similarly, simultaneously, supplement, title, tolerated, trend, unamortized, undelivered, unpaid, vein
Valuein 2011 FY filing- Value in 2012 FY filing
Original filings
Filing view